Leukemia Clinical Trials

A listing of Leukemia medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

UPDATED

Gilbert Arizona

Study of Iomab-B Prior to HCT vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory AML

UPDATED

Phoenix Arizona 85016

Patients are needed to participate in a clinical research study evaluating Apixaban and No systemic anticoagulant prophylaxis for the treatment of Lymphoma or Acute Lymphoblastic Leukemia

California

UPDATED

Duarte California 91010

A clinical trial to evaluate treatments using AMG 673 for patients with Acute Myeloid Leukemia

UPDATED

Duarte California 91010

A clinical trial to evaluate treatments using Guadecitabine and Treatment Choice for patients with Myelodysplastic Syndromes or Leukemia, Myelomonocytic, Chronic

UPDATED

Duarte California 91010

Patients are needed to participate in a clinical research study evaluating Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody and Guadecitabine for the treatment of Acute Myeloid Leukemia

UPDATED

Duarte California 91010

Patients are needed to participate in a clinical research study of oral rigosertib and Azacitidine to evaluate Myelodysplastic Syndrome, Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia

UPDATED

La Jolla California 92093

Patients are needed to participate in a clinical research study evaluating Tipifarnib for the treatment of Leukemia, Myelomonocytic, Chronic

View More ▼

UPDATED

Loma Linda California 92350

Patients are needed to participate in a clinical research study evaluating Apixaban and No systemic anticoagulant prophylaxis for the treatment of Lymphoma or Acute Lymphoblastic Leukemia

UPDATED

Los Angeles California 90027

A clinical trial seeking patients for a research study of BPX-501 T cells and AP1903 and AP1903

UPDATED

Los Angeles California 90095

A clinical trial to evaluate treatments using BMS-936564 and Cytarabine for patients with Leukemia

UPDATED

Los Angeles California 90095

Mechanisms of Idelalisib-Associated Diarrhea in Patients With Relapsed Chronic Lymphocytic Leukemia, Indolent Non-hodgkin Lymphoma, or Small Lymphocytic Lymphoma

UPDATED

Los Angeles California 90027

Patients are needed to participate in a clinical research study evaluating Apixaban and No systemic anticoagulant prophylaxis for the treatment of Lymphoma or Acute Lymphoblastic Leukemia

UPDATED

Los Angeles California 90003

Patients are needed to participate in a clinical research study of ASP2215 and Placebo to evaluate Acute Myeloid Leukemia (AML) or Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) / Internal Tandem Duplication (ITD) Mutation

UPDATED

Orange California 92868

Patients are needed to participate in a clinical research study evaluating Apixaban and No systemic anticoagulant prophylaxis for the treatment of Lymphoma or Acute Lymphoblastic Leukemia

UPDATED

Palo Alto California 94304

A clinical trial seeking patients for a research study of BPX-501 T cells and AP1903 and AP1903

UPDATED

Rancho Mirage California 92270

A clinical trial to evaluate treatments using Guadecitabine and Treatment Choice for patients with Myelodysplastic Syndromes or Leukemia, Myelomonocytic, Chronic

UPDATED

Rancho Mirage California 92270

Patients are needed to participate in a clinical research study of oral rigosertib and Azacitidine to evaluate Myelodysplastic Syndrome, Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia

UPDATED

Whittier California 90603

Patients are needed to participate in a clinical research study of ASP2215 and Placebo to evaluate Acute Myeloid Leukemia (AML) or Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) / Internal Tandem Duplication (ITD) Mutation

Connecticut

UPDATED

Hartford Connecticut 06106

Patients are needed to participate in a clinical research study evaluating Apixaban and No systemic anticoagulant prophylaxis for the treatment of Lymphoma or Acute Lymphoblastic Leukemia

UPDATED

New Haven Connecticut 06511

Patients are needed to participate in a clinical research study evaluating Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody and Guadecitabine for the treatment of Acute Myeloid Leukemia

UPDATED

New Haven Connecticut

Study of Iomab-B Prior to HCT vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory AML

Delaware

UPDATED

Wilmington Delaware 19803

Patients are needed to participate in a clinical research study evaluating Apixaban and No systemic anticoagulant prophylaxis for the treatment of Lymphoma or Acute Lymphoblastic Leukemia

District of Columbia

UPDATED

Washington District of Columbia 20010

A clinical trial seeking patients for a research study of BPX-501 T cells and AP1903 and AP1903

Florida

UPDATED

Fleming Island Florida 32003

A clinical trial to evaluate treatments using Guadecitabine and Treatment Choice for patients with Myelodysplastic Syndromes or Leukemia, Myelomonocytic, Chronic

UPDATED

Fort Myers Florida 33908

Patients are needed to participate in a clinical research study evaluating Apixaban and No systemic anticoagulant prophylaxis for the treatment of Lymphoma or Acute Lymphoblastic Leukemia

UPDATED

Gainesville Florida 32610-0278

Patients are needed to participate in a clinical research study of ASP2215 and Placebo to evaluate Acute Myeloid Leukemia (AML) or Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) / Internal Tandem Duplication (ITD) Mutation

UPDATED

Jacksonville Florida 32207

Patients are needed to participate in a clinical research study evaluating Apixaban and No systemic anticoagulant prophylaxis for the treatment of Lymphoma or Acute Lymphoblastic Leukemia

UPDATED

Jacksonville Florida 32204

Patients are needed to participate in a clinical research study of ASP2215 and Placebo to evaluate Acute Myeloid Leukemia (AML) or Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) / Internal Tandem Duplication (ITD) Mutation

View More ▼

UPDATED

Jacksonville Florida

Study of Iomab-B Prior to HCT vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory AML

UPDATED

Miami Beach Florida 33140

A clinical trial to evaluate treatments using Guadecitabine and Treatment Choice for patients with Myelodysplastic Syndromes or Leukemia, Myelomonocytic, Chronic

UPDATED

Orlando Florida 32806

A clinical trial to evaluate treatments using BMS-936564 and Cytarabine for patients with Leukemia

UPDATED

Pensacola Florida 32504

Patients are needed to participate in a clinical research study evaluating Apixaban and No systemic anticoagulant prophylaxis for the treatment of Lymphoma or Acute Lymphoblastic Leukemia

UPDATED

St. Petersburg Florida 33701

Patients are needed to participate in a clinical research study evaluating Apixaban and No systemic anticoagulant prophylaxis for the treatment of Lymphoma or Acute Lymphoblastic Leukemia

UPDATED

Tampa Florida 33612

Patients are needed to participate in a clinical research study evaluating Tipifarnib for the treatment of Leukemia, Myelomonocytic, Chronic

UPDATED

West Palm Beach Florida 33407

Patients are needed to participate in a clinical research study evaluating Apixaban and No systemic anticoagulant prophylaxis for the treatment of Lymphoma or Acute Lymphoblastic Leukemia

Georgia

UPDATED

Atlanta Georgia 30322

A clinical trial seeking patients for a research study of BPX-501 T cells and AP1903 and AP1903

UPDATED

Atlanta Georgia 30322

Patients are needed to participate in a clinical research study evaluating Apixaban and No systemic anticoagulant prophylaxis for the treatment of Lymphoma or Acute Lymphoblastic Leukemia

UPDATED

Atlanta Georgia 30342

Patients are needed to participate in a clinical research study to evaluate T-cell Type Acute Leukemia-Precursor T-lymphoblastic Lymphoma/Leukaemia

UPDATED

Augusta Georgia 30912

Patients are needed to participate in a clinical research study of ASP2215 and Placebo to evaluate Acute Myeloid Leukemia (AML) or Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) / Internal Tandem Duplication (ITD) Mutation

Idaho

UPDATED

Boise Idaho 83712

Patients are needed to participate in a clinical research study evaluating Apixaban and No systemic anticoagulant prophylaxis for the treatment of Lymphoma or Acute Lymphoblastic Leukemia

Illinois

UPDATED

Chicago Illinois 60612

A clinical trial to evaluate treatments using Guadecitabine and Treatment Choice for patients with Myelodysplastic Syndromes or Leukemia, Myelomonocytic, Chronic

UPDATED

Chicago Illinois 60612

Patients are needed to participate in a clinical research study of ASP2215 and Placebo to evaluate Acute Myeloid Leukemia (AML) or Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) / Internal Tandem Duplication (ITD) Mutation

UPDATED

Chicago Illinois 60612

Patients are needed to participate in a clinical research study of oral rigosertib and Azacitidine to evaluate Myelodysplastic Syndrome, Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia

UPDATED

Evanston Illinois 60201

A clinical trial to evaluate treatments using Guadecitabine and Treatment Choice for patients with Myelodysplastic Syndromes or Leukemia, Myelomonocytic, Chronic

UPDATED

Maywood Illinois

Study of Iomab-B Prior to HCT vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory AML

Iowa

UPDATED

Des Moines Iowa 50309

Patients are needed to participate in a clinical research study evaluating Apixaban and No systemic anticoagulant prophylaxis for the treatment of Lymphoma or Acute Lymphoblastic Leukemia

UPDATED

Iowa City Iowa

Patients are needed to participate in a clinical research study of SY-1425 (tamibarotene) to evaluate Acute Myeloid Leukemia or Myelodysplastic Syndrome

Kansas

UPDATED

Westwood Kansas

Study of Iomab-B Prior to HCT vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory AML

Kentucky

UPDATED

Louisville Kentucky 40207

A clinical research study of Venetoclax for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Louisville Kentucky 40202

Patients are needed to participate in a clinical research study evaluating Apixaban and No systemic anticoagulant prophylaxis for the treatment of Lymphoma or Acute Lymphoblastic Leukemia